ArticleAntimicrobial agents and chemotherapy2021
Azole resistance mechanisms in pathogenic
Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 82 citations in OpenAlex.
- Translational evaluation of magnetized saline water combined with ciclopirox olamine and piroctone olamine againstNarra J · 2026Article
- Azole-Driven Cross-Resistance and Transporter Gene Expression inMicroorganisms · 2026Article
- Global transcriptomic response ofFrontiers in veterinary science · 2026Article
- A novel enzymatic approach for a targeted fungal growth inhibition.BMC microbiology · 2025Article
- Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp.Mycoses · 2025Article
- Successful Treatment of Tinea Versicolor With Salicylic Acid 30% Peel.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025Article
- Non-synonymous ERG11 mutations inMicrobiology spectrum · 2025Article
- Comparative efficacy of selenoureido carbonic anhydrase inhibitors and azole antifungal drugs against clinical isolates of Malassezia pachydermatis.Veterinary dermatology · 2025Article
- Evaluation of Satanin 1 as a potential antifungal antimicrobial peptide to treat Malassezia infections.Scientific reports · 2025Article
- Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape.Dermatology and therapy · 2025Review
- The underestimated role of major skin commensalHeliyon · 2024Article
- Article
- Combinatory Use of hLF(1-11), a Synthetic Peptide Derived from Human Lactoferrin, and Fluconazole/Amphotericin B againstAntibiotics (Basel, Switzerland) · 2024Article
- Anti-Heliyon · 2024Article
- Safety, Efficacy and Attributes of 2.5% Selenium Sulfide Shampoo in the Treatment of Dandruff: A Single-Center Study.Cureus · 2024Article
- The burden of dermatitis from 1990-2019 in the Middle East and North Africa region.BMC public health · 2024Article
- Development and Validation of a Gas Chromatography-Mass Spectrometry Method for the Analysis of the Novel Plant-Based Substance with Antimicrobial Activity.Antibiotics (Basel, Switzerland) · 2023Article
- In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agentsBiomedica : revista del Instituto Nacional de Salud · 2023Article
- Antimicrobial Susceptibility Testing for ThreeMicrobiology spectrum · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.